KLK3 and cancer: Though, men with type 2 diabetes typically present with low PSA levels, which might result in cancer underdiagnosis [31] as supported by the REDUCE trial (where participants were required to undergo biopsy regardless of PSA values) which failed to show an association between diabetes and PCa risk [32].